Sarepta Therapeutics Inc (NASDAQ:SRPT)

During the Trading Day
13.42 +0.21 / +1.59%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.42 0.00 / 0.00%
 
Volume: 2.8K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$545.7M

Company Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Contact Information

Sarepta Therapeutics, Inc.
215 First Street
Cambridge Massachusetts 02142
P:(857) 242-3700
Investor Relations:
(857) 242-3714

Employees

Shareholders

Mutual fund holders35.95%
Other institutional28.90%
Individual stakeholders0.60%

Top Executives

Christopher Nishan GarabedianPresident, Chief Executive Officer & Director
Sandesh MahatmeSenior VP, Chief Financial & Accounting Officer
Patrick L. IversenSenior Vice President-Research & Innovation
Edward M. KayeChief Medical Officer & Senior Vice President
David Tyronne HowtonSecretary, Senior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.